COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. Issue 1 (January 2022)
- Record Type:
- Journal Article
- Title:
- COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. Issue 1 (January 2022)
- Main Title:
- COVID-19 Severity in Multiple Sclerosis
- Authors:
- Sormani, Maria Pia
Schiavetti, Irene
Carmisciano, Luca
Cordioli, Cinzia
Filippi, Massimo
Radaelli, Marta
Immovilli, Paolo
Capobianco, Marco
De Rossi, Nicola
Brichetto, Giampaolo
Cocco, Eleonora
Scandellari, Cinzia
Cavalla, Paola
Pesci, Ilaria
Zito, Antonio
Confalonieri, Paolo
Marfia, Girolama Alessandra
Perini, Paola
Inglese, Matilde
Trojano, Maria
Brescia Morra, Vincenzo
Tedeschi, Gioacchino
Comi, Giancarlo
Battaglia, Mario Alberto
Patti, Francesco
Salvetti, Marco
Abbadessa, Gianmarco
Aguglia, Umberto
Allegorico, Lia
Allegri Rossi, Beatrice Maria
Amato, Maria Pia
Annovazzi, Pietro
Antozzi, Carlo
Appendino, Lucia
Arena, Sebastiano
Baione, Viola
Balgera, Roberto
Barcella, Valeria
Baroncini, Damiano
Barrilà, Caterina
Bellacosa, Alessandra
Bellucci, Gianmarco
Bergamaschi, Roberto
Bergamaschi, Valeria
Bezzini, Daiana
Biolzi, Beatrice
Bisecco, Alvino
Bonavita, Simona
Borriello, Giovanna
Bosa, Chiara
Bosco, Antonio
Bovis, Francesca
Bozzali, Marco
Brambilla, Laura
Buccafusca, Maria
Bucciantini, Elisabetta
Bucello, Sebastiano
Buscarinu, Maria Chiara
Cabboi, Maria Paola
Calabrese, Massimiliano
Calabria, Francesca
Caleri, Francesca
Camilli, Federico
Caniatti, Luisa Maria
Cantello, Roberto
Capra, Ruggero
Capuano, Rocco
Carta, Patrizia
Celani, Maria Grazia
Cellerino, Maria
Cerqua, Raffaella
Chisari, Clara
Clerici, Raffaella
Clerico, Marinella
Cola, Gaia
Conte, Antonella
Conti, Marta Zaffira
Cordano, Christian
Cordera, Susanna
Corea, Francesco
Correale, Claudio
Cottone, Salvatore
Crescenzo, Francesco
Curti, Erica
d'Ambrosio, Alessandro
D'Amico, Emanuele
Danni, Maura Chiara
d'Arma, Alessia
Dattola, Vincenzo
de Biase, Stefano
Luca, Giovanna De
Mercanti, Stefania Federica De
De Mitri, Paolo
De Stefano, Nicola
Cava, Marco Della
Napoli, Mario di
Sapio, Alessia Di
Docimo, Renato
Dutto, Anna
Evangelista, Luana
Fanara, Salvatore
Diana, Ferraro
Ferrò, Maria Teresa
Fioretti, Cristina
Fratta, Mario
Frau, Jessica
Fronza, Marzia
Furlan, Roberto
Gajofatto, Alberto
Gallo, Antonio
Gallo, Paolo
Gasperini, Claudio
Ghazaryan, Anna
Giometto, Bruno
Gobbin, Francesca
Govone, Flora
Granella, Franco
Grange, Erica
Grasso, Maria Grazia
Guareschi, Angelica
Guaschino, Clara
Guerrieri, Simone
Guidetti, Donata
Iaffaldano, Pietro
Ianniello, Antonio
Iasevoli, Luigi
Imperiale, Daniele
Infante, Maria Teresa
Iodice, Rosa
Iovino, Aniello
Konrad, Giovanna
Landi, Doriana
Lanzillo, Roberta
Lapucci, Caterina
Lavorgna, Luigi
L'Episcopo, Maria Rita
Leva, Serena
Liberatore, Giuseppe
Lo Re, Marianna
Longoni, Marco
Lopiano, Leonardo
Lorefice, Lorena
Lucchini, Matteo
Lus, Giacomo
Maimone, Davide
Malentacchi, Maria
Mallucci, Giulia
Malucchi, Simona
Mancinelli, Chiara Rosa
Mancinelli, Luca
Manganotti, Paolo
Maniscalco, Giorgia Teresa
Mantero, Vittorio
Marangoni, Sabrina
Marastoni, Damiano
Marinelli, Fabiana
Marti, Alessandro
Boneschi, Filippo Martinelli
Masserano Zoli, Federco
Matta, Francesca
Mendozzi, Laura
Meucci, Giuseppe
Miante, Silvia
Miele, Giuseppina
Milano, Eva
Mirabella, Massimiliano
Missione, Rosanna
Moccia, Marcello
Moiola, Lucia
Montepietra, Sara
MontiBragadin, Margherita
Montini, Federico
Motta, Roberta
Nardone, Raffaele
Nicoletti, Carolina Gabri
Nobile-Orazio, Eduardo
Nozzolillo, Agostino
Onofrj, Marco
Orlandi, Riccardo
Palmieri, Anna
Paolicelli, Damiano
Pasquali, Livia
Pastò, Luisa
Pedrazzoli, Elisabetta
Petracca, Maria
Petrone, Alfredo
Piantadosi, Carlo
Pietroboni, Anna M
Pinardi, Federica
Ponzano, Marta
Portaccio, Emilio
Pozzato, Mattia
Pozzilli, Carlo
Prosperini, Luca
Protti, Alessandra
Ragonese, Paolo
Rasia, Sarah
Realmuto, Sabrina
Repice, Anna
Rigoni, Eleonora
Rilla, Maria Teresa
Rinaldi, Francesca
Romano, Calogero Marcello
Ronzoni, Marco
Rovaris, Marco
Ruscica, Francesca
Sabattini, Loredana
Salemi, Giuseppe
Saraceno, Lorenzo
Sartori, Alessia
Sartori, Arianna
Sbragia, Elvira
Scarano, Giuditta Ilaria
Scarano, Valentina
Schillaci, Valentina
Sessa, Maria
Sgarito, Caterina
Sibilia, Grazia
Siciliano, Gabriele
Signori, Alessio
Signoriello, Elisabetta
Sinisi, Leonardo
Sireci, Francesca
Sola, Patrizia
Solaro, Claudio
Sotgiu, Stefano
Sparaco, Maddalena
Stromillo, Maria Laura
Strumia, Silvia
Susani, Emanuela Laura
Tabiadon, Giulietta
Teatini, Francesco
Tomassini, Valentina
Tonietti, Simone
Torri, Clerici Valentina
Tortorella, Carla
Toscano, Simona
Totaro, Rocco
Trotta, Maria
Turano, Gabriella
Ulivelli, Monica
Valentino, Manzo
Vaula, Giovanna
Vecchio, Domizia
Vercellino, Marco
Verrengia, Elena Pinuccia
Vianello, Marika
Virgilio, Eleonora
Vitetta, Francesca
Vollaro, Stefano
Zaffaroni, Mauro
Zampolini, Mauro
Zarbo, Ignazio Roberto
Zuliani, Luigi
… (more) - Abstract:
- Abstract : Background and Objectives: It is unclear how multiple sclerosis (MS) affects the severity of COVID-19. The aim of this study is to compare COVID-19–related outcomes collected in an Italian cohort of patients with MS with the outcomes expected in the age- and sex-matched Italian population. Methods: Hospitalization, intensive care unit (ICU) admission, and death after COVID-19 diagnosis of 1, 362 patients with MS were compared with the age- and sex-matched Italian population in a retrospective observational case-cohort study with population-based control. The observed vs the expected events were compared in the whole MS cohort and in different subgroups (higher risk: Expanded Disability Status Scale [EDSS] score > 3 or at least 1 comorbidity, lower risk: EDSS score ⩽ 3 and no comorbidities) by the χ 2 test, and the risk excess was quantified by risk ratios (RRs). Results: The risk of severe events was about twice the risk in the age- and sex-matched Italian population: RR = 2.12 for hospitalization ( p < 0.001), RR = 2.19 for ICU admission ( p < 0.001), and RR = 2.43 for death ( p < 0.001). The excess of risk was confined to the higher-risk group (n = 553). In lower-risk patients (n = 809), the rate of events was close to that of the Italian age- and sex-matched population (RR = 1.12 for hospitalization, RR = 1.52 for ICU admission, and RR = 1.19 for death). In the lower-risk group, an increased hospitalization risk was detected in patients on anti-CD20 (RR = 3.03,Abstract : Background and Objectives: It is unclear how multiple sclerosis (MS) affects the severity of COVID-19. The aim of this study is to compare COVID-19–related outcomes collected in an Italian cohort of patients with MS with the outcomes expected in the age- and sex-matched Italian population. Methods: Hospitalization, intensive care unit (ICU) admission, and death after COVID-19 diagnosis of 1, 362 patients with MS were compared with the age- and sex-matched Italian population in a retrospective observational case-cohort study with population-based control. The observed vs the expected events were compared in the whole MS cohort and in different subgroups (higher risk: Expanded Disability Status Scale [EDSS] score > 3 or at least 1 comorbidity, lower risk: EDSS score ⩽ 3 and no comorbidities) by the χ 2 test, and the risk excess was quantified by risk ratios (RRs). Results: The risk of severe events was about twice the risk in the age- and sex-matched Italian population: RR = 2.12 for hospitalization ( p < 0.001), RR = 2.19 for ICU admission ( p < 0.001), and RR = 2.43 for death ( p < 0.001). The excess of risk was confined to the higher-risk group (n = 553). In lower-risk patients (n = 809), the rate of events was close to that of the Italian age- and sex-matched population (RR = 1.12 for hospitalization, RR = 1.52 for ICU admission, and RR = 1.19 for death). In the lower-risk group, an increased hospitalization risk was detected in patients on anti-CD20 (RR = 3.03, p = 0.005), whereas a decrease was detected in patients on interferon (0 observed vs 4 expected events, p = 0.04). Discussion: Overall, the MS cohort had a risk of severe events that is twice the risk than the age- and sex-matched Italian population. This excess of risk is mainly explained by the EDSS score and comorbidities, whereas a residual increase of hospitalization risk was observed in patients on anti-CD20 therapies and a decrease in people on interferon. … (more)
- Is Part Of:
- Neurology. Volume 9:Issue 1(2022)
- Journal:
- Neurology
- Issue:
- Volume 9:Issue 1(2022)
- Issue Display:
- Volume 9, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 9
- Issue:
- 1
- Issue Sort Value:
- 2022-0009-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-01
- Subjects:
- Neuroimmunology -- Periodicals
Neurology -- Periodicals
616.8 - Journal URLs:
- http://nn.neurology.org/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1212/NXI.0000000000001105 ↗
- Languages:
- English
- ISSNs:
- 2332-7812
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.502260
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25864.xml